These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 11248401

  • 21. Correction of hyperleucinemia in MSUD patients on leucine-free dietary therapy.
    Scott AI, Cusmano-Ozog K, Enns GM, Cowan TM.
    Mol Genet Metab; 2017 Dec; 122(4):156-159. PubMed ID: 29032949
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A new protein substitute for adolescents and adults with maple syrup urine disease (MSUD).
    Hallam P, Lilburn M, Lee PJ.
    J Inherit Metab Dis; 2005 Dec; 28(5):665-72. PubMed ID: 16151896
    [Abstract] [Full Text] [Related]

  • 26. Plasma amino acid and urine organic acid profiles of Filipino patients with maple syrup urine disease (MSUD) and correlation with their neurologic features.
    Chiong MA, Tan MA, Cordero CP, Fodra EG, Manliguis JS, Lopez CP, Dalmacio LM.
    Mol Genet Metab Rep; 2016 Dec; 9():46-53. PubMed ID: 27761412
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Protein and leucine metabolism in maple syrup urine disease.
    Thompson GN, Bresson JL, Pacy PJ, Bonnefont JP, Walter JH, Leonard JV, Saudubray JM, Halliday D.
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E654-60. PubMed ID: 2185648
    [Abstract] [Full Text] [Related]

  • 30. Repeated post-exercise administration with a mixture of leucine and glucose alters the plasma amino acid profile in Standardbred trotters.
    Nostell KE, Essén-Gustavsson B, Bröjer JT.
    Acta Vet Scand; 2012 Feb 01; 54(1):7. PubMed ID: 22296999
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect.
    Mescka CP, Wayhs CA, Vanzin CS, Biancini GB, Guerreiro G, Manfredini V, Souza C, Wajner M, Dutra-Filho CS, Vargas CR.
    Int J Dev Neurosci; 2013 Feb 01; 31(1):21-4. PubMed ID: 23137711
    [Abstract] [Full Text] [Related]

  • 33. Effects of amitriptyline on rat plasma and brain content of monoamine precursors and other large neutral amino acids.
    Eriksson T, Eriksson TE.
    J Pharm Pharmacol; 1995 Dec 01; 47(12A):1007-14. PubMed ID: 8932685
    [Abstract] [Full Text] [Related]

  • 34. Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.
    Vilela TC, Scaini G, Furlanetto CB, Pasquali MA, Santos JP, Gelain DP, Moreira JC, Schuck PF, Ferreira GC, Streck EL.
    Metab Brain Dis; 2017 Feb 01; 32(1):115-122. PubMed ID: 27510712
    [Abstract] [Full Text] [Related]

  • 35. Living related versus deceased donor liver transplantation for maple syrup urine disease.
    Feier F, Schwartz IV, Benkert AR, Seda Neto J, Miura I, Chapchap P, da Fonseca EA, Vieira S, Zanotelli ML, Pinto e Vairo F, Camelo JS, Margutti AV, Mazariegos GV, Puffenberger EG, Strauss KA.
    Mol Genet Metab; 2016 Mar 01; 117(3):336-43. PubMed ID: 26786177
    [Abstract] [Full Text] [Related]

  • 36. Creatine kinase activity from rat brain is inhibited by branched-chain amino acids in vitro.
    Pilla C, Cardozo RF, Dutra-Filho CS, Wyse AT, Wajner M, Wannmacher CM.
    Neurochem Res; 2003 May 01; 28(5):675-9. PubMed ID: 12716015
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Brain-blood amino acid correlates following protein restriction in murine maple syrup urine disease.
    Vogel KR, Arning E, Wasek BL, McPherson S, Bottiglieri T, Gibson KM.
    Orphanet J Rare Dis; 2014 May 08; 9():73. PubMed ID: 24886632
    [Abstract] [Full Text] [Related]

  • 39. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
    Mescka CP, Wayhs CA, Guerreiro G, Manfredini V, Dutra-Filho CS, Vargas CR.
    Gene; 2014 Sep 15; 548(2):294-8. PubMed ID: 25046137
    [Abstract] [Full Text] [Related]

  • 40. Intrahippocampal administration of the branched-chain alpha-hydroxy acids accumulating in maple syrup urine disease compromises rat performance in aversive and non-aversive behavioral tasks.
    Vasques Vde C, Brinco F, Wajner M.
    J Neurol Sci; 2005 May 15; 232(1-2):11-21. PubMed ID: 15850577
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.